| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $27.1M | -0.3% |
| SG&A Expense | $11.3M | +52.0% |
| Operating Income | -$38.3M | -10.9% |
| Interest Expense | $6.0M | +34.5% |
| Pre-tax Income | -$40.8M | -16.4% |
| Income Tax | $2K | -5.5% |
| Net Income | -$40.8M | -16.4% |
| EPS (Basic) | -$0.13 | -8.3% |
| EPS (Diluted) | -$0.13 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.9M | -52.6% |
| Short-term Investments | $53.7M | -6.9% |
| Inventory | $2.8M | — |
| Current Assets | $64.5M | -13.3% |
| Total Assets | $73.6M | -6.8% |
| Current Liabilities | $8.3M | +29.2% |
| Long-term Debt | $41.8M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.2M | -26.1% |
| Capital Expenditures | $273K | -22.8% |
| Investing Cash Flow | $1.1M | +112.9% |
| Financing Cash Flow | $32.5M | -19.7% |
| Free Cash Flow | -$41.5M | -25.6% |
| -8.3% |
| Total Liabilities |
| $49.2M |
| +2.8% |
| Stockholders' Equity | $24.4M | -21.6% |